2024-09-11 - Analysis Report
## ISRG Stock Analysis Report

**Company:** Intuitive Surgical, Inc. (ISRG) is a leading developer, manufacturer, and marketer of robotic-assisted surgical systems.

**Performance vs. S&P 500:**

* **Cumulative Return:** ISRG (99.24%) significantly outperformed the S&P 500 (VOO) (83.37%).
* **Relative Performance:** The current relative performance of ISRG against VOO is 15.87% (62.32% on a relative scale). This means ISRG has outperformed VOO by 15.87%, and its performance is better than 62.32% of its historical performance range. 

**Recent Price Action:**

* **Closing Price:** $479.39
* **Moving Averages:** 5-day ($478.61), 20-day ($480.58), 60-day ($454.52) 
* **Analysis:** The price is currently trading slightly below its 20-day moving average and above its 5-day and 60-day moving averages, suggesting a slight short-term downtrend.

**Technical Indicators:**

* **RSI:** 47.75 - The RSI indicates that the stock is currently in neutral territory, neither overbought nor oversold.
* **PPO:** -0.52 - The PPO indicates a slight bearish momentum, suggesting potential for further downward pressure. 
* **Delta_Previous_Relative_Divergence:** 1.51 (-) - This indicates a slight short-term downward divergence in relative price action.
* **Expected Return:** 16.1% - This represents the potential 5-year expected return based on current investment. 

**Recent Earnings & Outlook:**

| Date  | EPS  | Revenue  |
|---|---|---|
| 2024-07-19 | 1.48 | 2.01 B$ |
| 2024-04-19 | 1.54 | 1.89 B$ |
| 2023-10-20 | 1.18 | 1.74 B$ |
| 2023-07-24 | 1.20 | 1.76 B$ |
| 2024-07-19 | 1.20 | 1.76 B$ |

* **Analysis:** ISRG has consistently exceeded revenue expectations over the past few quarters. However, the recent EPS for Q2 2024 was slightly lower than estimates. This could be attributed to increased competition in the robotic surgery market. The company's long-term growth prospects remain strong, driven by the expanding adoption of minimally invasive surgical techniques and the increasing demand for robotic surgical systems.

**Overall Analysis:**

ISRG has shown strong performance in the past, consistently outperforming the S&P 500. While recent technical indicators suggest a slight short-term bearish momentum, the company's long-term fundamentals remain strong. The company has a history of exceeding revenue expectations, and its growth prospects are fueled by the increasing demand for robotic-assisted surgeries. However, investors should monitor the competition and the potential impact on ISRG's market share. 
